Skip to content
Home/Companies/Biotech/PDS Biotechnology

PDS Biotechnology

Biotech·United States·Active·12yr hold
Entry
2014
Hold
12yr
Status
Active

Who owns PDS Biotechnology?

PDS Biotechnology is currently owned by EMV Capital through EMV Capital Evergreen Fund (2012 vintage), since 2014.

Hand-verified · updated 2026-07-17

EMV Capital
Investor
EMV Capital
EMV Capital Evergreen Fund · 2012 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from EMV Capital Evergreen Fund

Other portfolio companies in the same fund.

Dogtooth Technologies
Active
TMTUK· 2026
AMR Bio
AMR Bio
Active
BiotechUK· 2025
Dname-iT
Active
SoftwareUK· 2023
DeepTech Recycling
DeepTech Recycling
Active
ClimateTechUK· 2022
Ventive
Ventive
Active
TMTUK· 2022
Cetromed
Active
BiotechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track PDS Biotechnology

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on PDS Biotechnology.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue